Lamotrigine versus levetiracetam or zonisamide for focal epilepsy and valproate versus levetiracetam for generalised and unclassified epilepsy: two SANAD II non-inferiority RCTs.
Marson AG, Burnside G, Appleton R, Smith D, Leach JP, Sills G, Tudur-Smith C, Plumpton CO, Hughes DA, Williamson PR, Baker G, Balabanova S, Taylor C, Brown R, Hindley D, Howell S, Maguire M, Mohanraj R, Smith PE.
Marson AG, et al.
Health Technol Assess. 2021 Dec;25(75):1-134. doi: 10.3310/hta25750.
Health Technol Assess. 2021.
PMID: 34931602
Free article.
Clinical Trial.
FUTURE WORK: SANAD II data could now be included in an individual participant meta-analysis of similar trials, and future similar trials are required to assess the clinical effectiveness and cost-effectiveness of other new treatments, including lacosamide and perampanel. C …
FUTURE WORK: SANAD II data could now be included in an individual participant meta-analysis of similar trials, and future similar trials are …